Nav: Home

Haphazard cholesterol checks put Australians at risk of heart disease

March 08, 2018

A research team from Western Sydney University, Capital Markets CRC, University of Sydney and University of Adelaide did an analysis of publicly available, linked patient records within the electronic databases of the Medicare Benefit Schedule (MBS) and Pharmaceutical Benefit Scheme (PBS).

The results reveal:

49 per cent of patients on medications to lower their cholesterol did not have the recommended annual HDL-C test in a given year.

19 per cent of the same population received more HDL-C tests than were necessary.

the yearly expenditure associated with test overutilisation was approximately A$4.3 million, while the cost averted because of test underutilisation was approximately A$11.3 million per year.

Using the PBS data, the researchers collated the de-identified records of patients who received stable prescriptions of cholesterol lowering medications over a 7-year period from 2008 to 2014 - who could therefore be determined as being at high risk of developing heart disease.

As patient records are linked to the MBS, it was then possible to determine if these same patients received the recommended, annual High-Density Lipoprotein-Cholesterol (HDL-C) test from their GP.

Dr Evan Atlantis, from the School of Nursing and Midwifery at Western Sydney University, says the results suggest that one fifth of patients are receiving too many, unnecessary tests - while half are not having their blood cholesterol levels sufficiently monitored.

"Cholesterol tests are being administered in a haphazard manner - with some patients being tested too frequently and others not enough," says Dr Atlantis.

The BMJ Open paper explores several possible explanations for this finding. One points to a lack in continuity of care and to the fact that often people see multiple practitioners at once.

"If there is no designated 'medical home' for the patient, it is not clear who bears the responsibility for managing cardiovascular risk. In this scenario, it is not surprising that many individuals may miss their annual cholesterol tests," says Dr Atlantis.

"Another contributing factor may be the lack of continuity in medical records. It is entirely possible that practitioners are not aware that some of their patients are on cholesterol medications and therefore do not take the recommended action in ordering tests.

"Another possibility is that medical practitioners are making a clinical choice not to follow the current guidelines on blood cholesterol monitoring."

Dr Atlantis - together with co-researcher Dr Katy Bell from the University of Sydney - suggests that medical practitioners' widespread non-adherence may be evidence that the guidelines warrant review.

"If there is high level evidence that the recommended frequency of tests leads to improved health outcomes, then the potential underutilisation of these tests in Australia warrants further attention," says Dr Bell.

The study also identified the Federal Health Budget implications of the underutilisation of cholesterol tests.

During the study period, the yearly expenditure associated with test overutilisation was approximately A$4.3 million, while the cost averted because of test underutilisation was approximately A$11.3 million per year.

"While cost-saving, the long term health consequences of under-utilising HDL-C test are unknown and any increase in heart disease in Australia would result in a financial burden that cannot be ignored," says Dr Atlantis.

Farshid Hajati - who developed the methodology to conduct the study and analysed the data - pointed out that there is great potential for data of this type to benefit the public.

"The next step is to quantify the consequences of not receiving the recommended level of cholesterol testing, to strengthen the current recommendations on testing frequency."
-end-


University of Sydney

Related Heart Disease Articles:

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.
With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.
Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.
Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.
Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.
New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.
Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.
Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.
Women once considered low risk for heart disease show evidence of previous heart attack scars
Women who complain about chest pain often are reassured by their doctors that there is no reason to worry because their angiograms show that the women don't have blockages in the major heart arteries, a primary cause of heart attacks in men.
Where you live could determine risk of heart attack, stroke or dying of heart disease
People living in parts of Ontario with better access to preventive health care had lower rates of cardiac events compared to residents of regions with less access, found a new study published in CMAJ (Canadian Medical Association Journal).
More Heart Disease News and Heart Disease Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Warped Reality
False information on the internet makes it harder and harder to know what's true, and the consequences have been devastating. This hour, TED speakers explore ideas around technology and deception. Guests include law professor Danielle Citron, journalist Andrew Marantz, and computer scientist Joy Buolamwini.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.